Clinical Trial: A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)

U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07199465) titled 'A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)' on Sept. 22.

Brief Summary: Researchers are looking for a way to prevent cytomegalovirus (CMV) in children and adolescents who receive a kidney transplant (KT) and weigh less than 40 kilograms (88.2 pounds). The goals of the study are to:

* Learn what happens to letermovir in the body overtime

* Learn about the safety of letermovir and if participants tolerate it

Study Start Date: Oct. 24

Study Type: INTERVENTIONAL

Condition: Cytomegalovirus Prophylaxis

Intervention: DRUG: Letermovir

Administered orally (a...